Filing Flows › America Great Health (AAGH) › Q3 FY26
America Great Health (AAGH) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed Aug 6, 2026
America Great Health (AAGH) reported revenue of $26K for the third quarter fiscal 2026 (Q3 FY26), -53% from a year earlier and -42% from the quarter before. Operating margin was -282.2%, net loss $166K (635.8% of revenue).
America Great Health, Q3 FY26: revenue $26K (-53% year over year), operating margin -282.2%, net loss $166K, operating cash flow $2K. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26K | -42% | -53% |
| Operating profit | −$74K | — | — |
| Net earnings | −$166K | -115% | — |
| Operating cash flow | $2K | — | — |
What changed
Revenue was $26K in Q3 FY26, down 53% year over year and down 42% from the previous quarter. Anti Aging Immune Support was the largest line at 54% of revenue. Anti Aging Immune Support lost $36K year over year (down 72%), 120% of the total change.
Gross margin was 86.2%, down 2.5 points from Q3 FY25. Operating costs exceeded revenue by $74K, an operating margin of -282.2%. Operating expenses fell 29% while revenue fell 53%. The quarter ended with a net loss of $166K, after a profit of $1.1M the previous quarter. Minority interests bore $0K of it: to shareholders the quarter was a loss of $166K. Net interest and other expense of $92K was the main reason.
Operating cash flow was $2K. Non-cash charges added back $1K of depreciation. Working capital and other items added $167K.
Questions
What was America Great Health's revenue in the third quarter fiscal 2026?
America Great Health (AAGH) reported revenue of $26K for the third quarter fiscal 2026 (Q3 FY26), -53% from a year earlier and -42% from the quarter before.
Was America Great Health profitable in the third quarter fiscal 2026?
Operating loss was $74K (-282.2% of revenue) and net loss $166K.